Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Androgen receptor splice variants drive castration-resistant prostate cancer metastasis by activating distinct transcriptional programs
Dong Han, Maryam Labaf, Yawei Zhao, et al.
Journal of Clinical Investigation (2024) Vol. 134, Iss. 11
Open Access | Times Cited: 12

Showing 12 citing articles:

Cyclin-dependent protein kinases and cell cycle regulation in biology and disease
Ilenia Pellarin, Alessandra Dall’Acqua, Andrea Favero, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 12
Precision Targeting in Metastatic Prostate Cancer: Molecular Insights to Therapeutic Frontiers
Whi‐An Kwon, Jae Young Joung
Biomolecules (2025) Vol. 15, Iss. 5, pp. 625-625
Open Access
AR-V7 condensates drive androgen-independent transcription in castration resistant prostate cancer
Shabnam Massah, Nicholas Pinette, Jane Foo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
IL-1β in Neoplastic Disease and the Role of Its Tumor-Derived Form in the Progression and Treatment of Metastatic Prostate Cancer
Yetunde Oyende, Luke J. Taus, Alessandro Fatatis
Cancers (2025) Vol. 17, Iss. 2, pp. 290-290
Open Access
Repurposing alternative splicing events as potential targets for the design of diagnostic and therapeutic tools in PCa
Nancy Martínez-Montiel, José de Jesús Vite-Arciniega, Nora Hilda Rosas-Murrieta, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Cyclin-dependent kinases as mediators of aberrant transcription in prostate cancer
Razia Rahman, Luke A. Selth
Translational Oncology (2025) Vol. 55, pp. 102378-102378
Closed Access
Targeting Androgen, Thyroid Hormone, and Vitamin A and D Receptors to Treat Prostate Cancer
Brigitte Hantusch, Lukas Kenner, Vesna S. Stanulović, et al.
(2024)
Open Access | Times Cited: 1
Targeting Androgen, Thyroid Hormone, and Vitamin A and D Receptors to Treat Prostate Cancer
Brigitte Hantusch, Lukas Kenner, Vesna S. Stanulović, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 17, pp. 9245-9245
Open Access | Times Cited: 1
Androgen receptor inhibitors in treating prostate cancer
Ryan N. Cole, Qinghua Fang, Kanako Matsuoka, et al.
Asian Journal of Andrology (2024)
Open Access | Times Cited: 1
Increased nuclear factor I-mediated chromatin access drives transition to androgen receptor splice variant dependence in prostate cancer
Larysa Poluben, Mannan Nouri, Jiaqian Liang, et al.
Cell Reports (2024) Vol. 44, Iss. 1, pp. 115089-115089
Open Access | Times Cited: 1
CYR61 promotes metastasis of prostate cancer cells through the p-AKT and AR signaling pathways
Greisha L. Ortiz-Hernández, Carmina S. Patrick, Stefan Hinz, et al.
Research Square (Research Square) (2024)
Closed Access
Nutraceuticals target androgen receptor-splice variants (AR-SV) to manage castration resistant prostate cancer (CRPC)
Ashish Tyagi, Balaji Chandrasekaran, Vaibhav Shukla, et al.
Pharmacology & Therapeutics (2024) Vol. 264, pp. 108743-108743
Closed Access
Page 1

Scroll to top